3-Methoxymollugin is utilized in biochemical and pharmacological research, particularly for its anti-inflammatory effects by inhibiting proteins such as NF-κB and reducing pro-inflammatory cytokine production, demonstrating potential as a lead compound for chronic inflammatory diseases like arthritis or type 2 diabetes. It also exhibits antioxidant properties due to its phenolic structure with a methoxy group, aiding in cellular protection against free radicals.

Additionally, studies highlight its role in supporting liver health and antiviral activity, especially against hepatitis B virus, positioning it as a candidate for therapeutic agent development. The compound has shown cytotoxic effects on cancer cell lines, including breast and liver cancer, through mechanisms involving apoptosis induction and inhibition of cell proliferation via regulation of cyclins and cyclin-dependent kinases, suggesting applications in oncology research.

Its structural features make it promising for use in dietary supplements or cosmetics focused on skin protection from aging and wrinkles.